Real-World Efficacy and Safety of Oral Tofacitinib in Patients with Refractory Moderate to Severe Atopic Dermatitis: A Multicenter Retrospective Study.

Indian J Dermatol · 2024 · PMC11407563 · PMID 39296687

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

When EASI and SCORAD values were compared before and after the administration of oral tofacitinib using paired T-tests, the two-tailed P values for both scores were less than 0.001, indicating a highly significant improvement [ Figures 1 and 2 ].

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.